Dr. Noble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8700 Beverly Blvd
West Hollywood, CA 90048Phone+1 310-423-8784Fax+1 310-423-2665- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
- University of California (San Francisco)Chief Residency, Internal Medicine, 1987 - 1988
- University of California (San Francisco)Residency, Internal Medicine, 1984 - 1987
- New York University School of MedicineClass of 1984
Certifications & Licensure
- CA State Medical License 2012 - 2024
- NC State Medical License 2006 - 2014
- CT State Medical License 1998 - 2007
- MD State Medical License 1992 - 1999
- CO State Medical License 1989 - 1993
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsSOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys.Karumanchi, A., Shikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco, Anna Rinaldi, Alex Rajewski, Jasper Callemeyn, Elisabet Van Loon, Baptiste Lamarthée,...> ;Science. 2024 Feb 23
- 1 citationsSenescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis.Tanyalak Parimon, Peter Chen, Barry R Stripp, Jiurong Liang, Dianhua Jiang, Paul W Noble, William C Parks, Changfu Yao> ;American Journal of Physiology. Cell Physiology. 2023 Aug 1
- 1 citationsPlasma cells: a feasible therapeutic target in pulmonary fibrosis?Amanda T Goodwin, Paul W Noble, Amanda L Tatler> ;The European Respiratory Journal. 2022 Nov 1
- Join now to see all
Press Mentions
- Pulmonary Fibrosis Foundation Adds Cedars-Sinai to Care Center NetworkDecember 23rd, 2022
- Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center NetworkDecember 16th, 2022
- Lassen Therapeutics Announces the Appointment of a Highly Experienced Biotech Executive to Its Board of Directors and the Expansion of Its Scientific and Clinical Advisory Board with Leading Experts in Pulmonary Fibrosis and Clinical DevelopmentOctober 7th, 2021
- Join now to see all
Grant Support
- Innate Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2008–2012
- Matrix Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2011
- Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2006–2011
- Interdisciplinary Training Program In Lung DiseaseNational Heart, Lung, And Blood Institute2006–2011
- Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute2006–2010
- Matrix Regulation Of Fibroproliferative Lung DiseaseNational Heart, Lung, And Blood Institute2006–2010
- Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2006
- Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2006
- Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2005–2006
- Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2003–2005
- Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2002–2005
- Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute1997–2005
- Regulation Of Macrophage Phenotypes In Lung RepairNational Heart, Lung, And Blood Institute1992–1996
Hospital Affiliations
- Cedars-Sinai Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: